Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Xavier Anglaret

Showing results (111-120 of 161) with videos related to

Pageof 17
Sort By:
The Pan African Medical Journal|March 29, 2019
[Aortic aneurism dissection in an adult patient with tuberculosis infected with HIV-1 during immune reconstitution inflammatory syndrome]Desmorys Raoul Moh, Anani Badjé, Nogbou Frederic Ello, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|December 17, 2011
AIDS and non-AIDS morbidity and mortality across the spectrum of CD4 cell counts in HIV-infected adults before starting antiretroviral therapy in Cote d'IvoireXavier Anglaret, Albert Minga, Delphine Gabillard, et al.
AIDS (London, England)|March 4, 2014
Genotypic resistance profiles of HIV-2-treated patients in West AfricaCharlotte Charpentier, Serge Eholié, Xavier Anglaret, et al.
Iscience|February 2, 2026
Self-collected finger-prick blood for gene expression profiling: Unveiling early immune responses in mild COVID-19Rodolphe Thiébaut, Edouard Lhomme, Hakim Hocini, et al.
The Journal of Infectious Diseases|August 14, 2018
Kinetics of Soluble Mediators of the Host Response in Ebola Virus DiseaseRomy Kerber, Ralf Krumkamp, Misa Korva, et al.
AIDS (London, England)|December 13, 2016
Virological efficacy of 24-week fozivudine-based regimen in ART-naive patients from Tanzania and Côte d'IvoireArne Kroidl, Frederic Ello, Jimson Mgaya, et al.
Antiviral Therapy|April 29, 2022
Higher risk of mortality in HIV-HBV co-infected patients from sub-Saharan Africa is observed at lower CD4<sup>+</sup> cell countsGérard M Kouamé, Delphine Gabillard, Raoul Moh, et al.
AIDS Research and Therapy|March 1, 2016
High prevalence of being Overweight and Obese HIV-infected persons, before and after 24 months on early ART in the ANRS 12136 Temprano TrialCalixte Guehi, Anani Badjé, Delphine Gabillard, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|April 16, 2014
Clinical impact and cost-effectiveness of making third-line antiretroviral therapy available in sub-Saharan Africa: a model-based analysis in Côte d'IvoireEric N Ouattara, Eric L Ross, Yazdan Yazdanpanah, et al.
The Journal of Antimicrobial Chemotherapy|September 17, 2021
Virological failure and drug resistance in West African HIV-infected adults who started ART immediately or deferred ART initiationDelphine Gabillard, Jean-Baptiste N'Takpé, Marie-Laure Chaix, et al.
Pageof 17

Showing results (111-120 of 161) with videos related to

Sort By:
Pageof 17
The Pan African Medical Journal|March 29, 2019
[Aortic aneurism dissection in an adult patient with tuberculosis infected with HIV-1 during immune reconstitution inflammatory syndrome]Desmorys Raoul Moh, Anani Badjé, Nogbou Frederic Ello, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|December 17, 2011
AIDS and non-AIDS morbidity and mortality across the spectrum of CD4 cell counts in HIV-infected adults before starting antiretroviral therapy in Cote d'IvoireXavier Anglaret, Albert Minga, Delphine Gabillard, et al.
AIDS (London, England)|March 4, 2014
Genotypic resistance profiles of HIV-2-treated patients in West AfricaCharlotte Charpentier, Serge Eholié, Xavier Anglaret, et al.
Iscience|February 2, 2026
Self-collected finger-prick blood for gene expression profiling: Unveiling early immune responses in mild COVID-19Rodolphe Thiébaut, Edouard Lhomme, Hakim Hocini, et al.
The Journal of Infectious Diseases|August 14, 2018
Kinetics of Soluble Mediators of the Host Response in Ebola Virus DiseaseRomy Kerber, Ralf Krumkamp, Misa Korva, et al.
AIDS (London, England)|December 13, 2016
Virological efficacy of 24-week fozivudine-based regimen in ART-naive patients from Tanzania and Côte d'IvoireArne Kroidl, Frederic Ello, Jimson Mgaya, et al.
Antiviral Therapy|April 29, 2022
Higher risk of mortality in HIV-HBV co-infected patients from sub-Saharan Africa is observed at lower CD4<sup>+</sup> cell countsGérard M Kouamé, Delphine Gabillard, Raoul Moh, et al.
AIDS Research and Therapy|March 1, 2016
High prevalence of being Overweight and Obese HIV-infected persons, before and after 24 months on early ART in the ANRS 12136 Temprano TrialCalixte Guehi, Anani Badjé, Delphine Gabillard, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|April 16, 2014
Clinical impact and cost-effectiveness of making third-line antiretroviral therapy available in sub-Saharan Africa: a model-based analysis in Côte d'IvoireEric N Ouattara, Eric L Ross, Yazdan Yazdanpanah, et al.
The Journal of Antimicrobial Chemotherapy|September 17, 2021
Virological failure and drug resistance in West African HIV-infected adults who started ART immediately or deferred ART initiationDelphine Gabillard, Jean-Baptiste N'Takpé, Marie-Laure Chaix, et al.
Pageof 17